Evidence map›Paper›PMID 17485504›Full record

ArticleAntimicrobial agents and chemotherapy2007

Amiodarone and bepridil inhibit anthrax toxin entry into host cells.

Ana M Sanchez, Diane Thomas, Eugene J Gillespie, Robert Damoiseaux, Joseph Rogers, Jonathan P Saxe, Jing Huang, Marianne Manchester, Kenneth A Bradley

Open access · greenAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cyclodextrins in the antiviral therapy.Journal of drug delivery science and technology · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Designing inhibitors of anthrax toxin.Expert opinion on drug discovery · 2014
    Review
  10. Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Novel strategies to combat bacterial virulence.Current opinion in critical care · 2008
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ana M SanchezDepartment of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Diane Thomas
Eugene J Gillespie
Robert Damoiseaux
Joseph Rogers
Jonathan P Saxe
Jing Huang
Marianne Manchester
Kenneth A Bradley
University of California, Los Angeles · USScripps Research Institute · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 1991 to 2018
$39.9M
Multivalent display of anthrax toxin inhibitorsP01AI056013 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MANCHESTER, MARIANNE · 2003 to 2007
$9.2M
CHARACTERIZATION OF ANTHRAX TOXIN RECEPTOR INTERACTIONSR01AI057870 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADLEY, KENNETH ALAN · 2004 to 2008
$1.7M
Host Factors Influencing Anthrax Toxin SensitivityF31AI061847 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SANCHEZ, ANA M · 2004 to 2005
$50k
NCI NIH HHS CA-16042NCI NIH HHS P30 CA016042NIAID NIH HHS 1-F31-AI-061847NIAID NIH HHS AI-057870NIAID NIH HHS AI-28697NIAID NIH HHS F31 AI061847NIAID NIH HHS P01 AI056013NIAID NIH HHS P01AI056013NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI057870
6 · The paper itself

Abstract

Anthrax lethal toxin is one of the fundamental components believed to be responsible for the virulence of Bacillus anthracis. In order to find novel compounds with anti-lethal toxin properties, we used a cell-based assay to screen a collection of approximately 500 small molecules. Nineteen compounds that blocked lethal toxin-mediated killing of RAW 264.7 macrophages were identified, and we report here on the characterization of the two most potent antitoxic compounds, amiodarone and bepridil. These drugs are used to treat cardiac arrhythmia or angina in humans at doses similar to those that provide protection against lethal toxin in vitro. Our results support a model whereby the antitoxic properties of both drugs result from their ability to block endosomal acidification, thereby blocking toxin entry. Amiodarone was tested in vivo and found to significantly increase survival of lethal toxin-challenged Fischer rats.

Indexed as

AmiodaroneAnimalsAnthraxAntigens, BacterialBacterial ToxinsBepridilCell LineCell SurvivalChloroquineCHO CellsCricetinaeCricetulusCyclic AMPDose-Response Relationship, DrugDrug Therapy, CombinationHydrogen-Ion ConcentrationAmiodaroneanthrax toxinAntigens, BacterialBacterial ToxinsBepridilChloroquineCyclic AMP

Identifiers

PMID17485504
PMCPMC1913235
OpenAlexW2100590301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.